← Back to Startups

Cellino

Cellino develops optical bioprocesses for patient-specific biomanufacturing.

Tracked VC backers
2
Visit cellinobio.com ↗
View in My Fund →

RiseFinder summary

Cellino uses AI-driven optical bioprocesses for patient-specific biomanufacturing. Its approach uses laser-generated bubbles to remove unwanted cells and control the density of cells during biomanufacturing.

Limited coverage
Tracking coverage and points

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Limited coverage
Homepage checked. Exit news coverage is not established.Homepage checked:

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Publicly documented VC backing

These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.

Felicis

Listed as “Cellino”

First observed:
31 Oct 2026
Investment announced:
Date not recorded
View source ↗

Dated public activity

No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.